In vitro activity of tigecycline against gram-positive and gram-negative pathogens as evaluated by broth microdilution and Etest
CM Pillar, DC Draghi, MJ Dowzicky… - Journal of clinical …, 2008 - Am Soc Microbiol
The current surveillance establishes the activity profile of tigecycline against recent clinical
US isolates of target pathogens. Findings from a distributed surveillance that utilized Etest …
US isolates of target pathogens. Findings from a distributed surveillance that utilized Etest …
In vitro activity of tigecycline against 3989 Gram-negative and Gram-positive clinical isolates from the United States Tigecycline Evaluation and Surveillance Trial …
SK Bouchillon, DJ Hoban, BM Johnson… - … and infectious disease, 2005 - Elsevier
The Tigecycline Evaluation and Surveillance Trial (TEST Program) determined the in vitro
activity of tigecycline over a large population of organisms from geographically diverse sites …
activity of tigecycline over a large population of organisms from geographically diverse sites …
Validation and reproducibility assessment of tigecycline MIC determinations by Etest
A Bolmström, A Karlsson, A Engelhardt… - Journal of clinical …, 2007 - Am Soc Microbiol
ABSTRACT A multicenter study was conducted to validate Etest tigecycline compared to the
Clinical Laboratory Standards Institute reference broth microdilution and agar dilution …
Clinical Laboratory Standards Institute reference broth microdilution and agar dilution …
Tigecycline activity tested against 26,474 bloodstream infection isolates: a collection from 6 continents
The activity of tigecycline (formerly GAR936), a novel glycylcycline, was tested against
recent bloodstream infection (BSI) pathogen isolates from 6 continents. Frequency of clinical …
recent bloodstream infection (BSI) pathogen isolates from 6 continents. Frequency of clinical …
Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia
TR Fritsche, HS Sader, MG Stilwell… - … and infectious disease, 2005 - Elsevier
Emerging antimicrobial resistance among respiratory tract pathogens has created a critical
need for development of new antimicrobial agents that are not affected by the commonly …
need for development of new antimicrobial agents that are not affected by the commonly …
In vitro activity of tigecycline and comparator agents against a global collection of Gram-negative and Gram-positive organisms: tigecycline Evaluation and …
MW Garrison, R Mutters, MJ Dowzicky - Diagnostic microbiology and …, 2009 - Elsevier
The Tigecycline Evaluation and Surveillance Trial began in 2004 to monitor the in vitro
activity of tigecycline and comparator agents against a global collection of Gram-negative …
activity of tigecycline and comparator agents against a global collection of Gram-negative …
Tigecycline activity tested against 11 808 bacterial pathogens recently collected from US medical centers
Tigecycline activity was evaluated against 11808 pathogens isolated from 30 US medical
centers. Susceptibility testing was performed by reference broth microdilution methods …
centers. Susceptibility testing was performed by reference broth microdilution methods …
In vitro evaluation of tigecycline and comparative agents in 3049 clinical isolates: 2001 to 2002
SK Bouchillon, DJ Hoban, BM Johnson… - … and infectious disease, 2005 - Elsevier
Tigecycline is the first glycylcycline antimicrobial in phase III clinical trials. This study
compares the in vitro activity of tigecycline to 12 other predominately broad-spectrum …
compares the in vitro activity of tigecycline to 12 other predominately broad-spectrum …
In vitro antibacterial activity of tigecycline against resistant Gram-negative bacilli and enterococci by time–kill assay
GA Pankey, DS Ashcraft - Diagnostic microbiology and infectious disease, 2009 - Elsevier
This time–kill study was performed with 65 genetically unique clinical isolates of Gram-
negative bacilli and enterococci to further define the antibacterial activity of tigecycline. To …
negative bacilli and enterococci to further define the antibacterial activity of tigecycline. To …
Tigecycline activity tested against multidrug-resistant Enterobacteriaceae and Acinetobacter spp. isolated in US medical centers (2005–2009)
We evaluated the activity of tigecycline against Enterobacteriaceae (9563 isolates) and
Acinetobacter spp.(835) with various resistance phenotypes collected from 31 US medical …
Acinetobacter spp.(835) with various resistance phenotypes collected from 31 US medical …